United States Biotechnology & Medical Research

Exact Sciences Corp (EXAS)

Track

Recent insider activity at Exact Sciences Corp. includes several planned and proposed sales by executives and directors, with the most recent transactions occurring on November 19, 2025. These sales represent a consistent pattern of divestment by key personnel over the past few months.
Stock chart
Ticker: EXAS Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
ORVILLE JACOB A
EVP, GM, Screening
2 sales — total 750,000 USD
Planned sale 19 Nov 2025
Value US$3,457,588.00 | Price 84.18 | Shares 30,956
Proposed sale 19 Nov 2025
Value US$3,957,907.67 | Price 274.58 | Shares 69,540
Planned sale 19 Nov 2025
Value US$2,118,877.19 | Price 246.76 | Shares 55,929
Proposed sale 19 Nov 2025
Value US$2,465,016.90 | Price 447.78 | Shares 31,729
Planned sale 4 Nov 2025
Value US$200,288.64 | Price 70.08 | Shares 2,858
Proposed sale 4 Nov 2025
Value US$200,288.64 | Price 70.08 | Shares 2,858
Planned sale 4 Nov 2025
Value US$105,120.00 | Price 70.08 | Shares 1,500
Proposed sale 4 Nov 2025
Value US$105,120.00 | Price 70.08 | Shares 1,500
Planned sale 24 Oct 2025
Value US$780,000.00 | Price 65.00 | Shares 12,000
Proposed sale 24 Oct 2025
Value US$780,000.00 | Price 65.00 | Shares 12,000
Planned sale 9 Oct 2025
Value US$90,000.00 | Price 60.00 | Shares 1,500
Proposed sale 9 Oct 2025
Value US$90,000.00 | Price 60.00 | Shares 1,500
Planned sale 9 Oct 2025
Value US$120,000.00 | Price 60.00 | Shares 2,000
Proposed sale 9 Oct 2025
Value US$120,000.00 | Price 60.00 | Shares 2,000
Planned sale 13 Aug 2025
Value US$62,399.70 | Price 42.02 | Shares 1,485
Proposed sale 13 Aug 2025
Value US$62,399.70 | Price 42.02 | Shares 1,485
Proposed sale 16 Jul 2025
Value US$433,605.12 | Price 53.11 | Shares 8,164
Planned sale 13 Jun 2025
Value US$170,612.40 | Price 53.20 | Shares 3,207
Proposed sale 13 Jun 2025
Value US$170,612.40 | Price 53.20 | Shares 3,207
Buy 13 Nov 2024
Value US$1,001,325.00 | Price 51.35 | Shares 19,500
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-11-21 2025-11-19 PlS Planned sale
ORVILLE JACOB A

EVP, GM, Screening

Officer
30,956 -7.1%
84.18
US$3,457,588 		30,956 -7.1% 84.18 US$3,457,588
2025-11-21 2025-11-19 PlS Planned sale
Herriott James

SVP, General Counsel & Sec

Officer
55,929 -16.0%
246.76
US$2,118,877 		55,929 -16.0% 246.76 US$2,118,877
2025-11-19 2025-11-19 PrS Proposed sale
ORVILLE JACOB A

Officer

Officer
69,540
274.58
US$3,957,908 		69,540 274.58 US$3,957,908
2025-11-19 2025-11-19 PrS Proposed sale
Herriott James

Officer

Officer
1,000
70.00
US$70,000 		1,000 70.00 US$70,000
2025-11-06 2025-11-04 PlS Planned sale
Baranick Brian

EVP, GM, Precision Oncology

Officer
2,858 -11.3%
70.08
US$200,289 		2,858 -11.3% 70.08 US$200,289
2025-11-06 2025-11-04 PlS Planned sale
Herriott James

SVP, General Counsel & Sec

Officer
1,500 -10.6%
70.08
US$105,120 		1,500 -10.6% 70.08 US$105,120
2025-11-04 2025-11-04 PrS Proposed sale
Baranick Brian

Officer

Officer
2,858
70.08
US$200,289 		2,858 70.08 US$200,289
2025-11-04 2025-11-04 PrS Proposed sale
Herriott James

Officer

Officer
1,500
70.08
US$105,120 		1,500 70.08 US$105,120
2025-10-27 2025-10-24 PlS Planned sale
3.8
Zanotti Katherine S
Non-Executive Director
12,000 -16.5%
65.00
US$780,000 		12,000 -16.5% 65.00 US$780,000
2025-10-24 2025-10-24 PrS Proposed sale
3.8
Zanotti Katherine S

Director

Non-Executive Director
12,000
65.00
US$780,000 		12,000 65.00 US$780,000
2025-10-10 2025-10-09 PlS Planned sale
Herriott James

SVP, General Counsel & Sec

Officer
1,500 -9.6%
60.00
US$90,000 		1,500 -9.6% 60.00 US$90,000
2025-10-10 2025-10-09 PlS Planned sale
Doyle James Edward
Non-Executive Director
2,000 -3.3%
60.00
US$120,000 		2,000 -3.3% 60.00 US$120,000
2025-10-09 2025-10-09 PrS Proposed sale
Herriott James

Officer

Officer
1,500
60.00
US$90,000 		1,500 60.00 US$90,000
2025-10-09 2025-10-09 PrS Proposed sale
Doyle James Edward

Director

Non-Executive Director
2,000
60.00
US$120,000 		2,000 60.00 US$120,000
2025-08-14 2025-08-13 PlS Planned sale
Doyle James Edward
Non-Executive Director
1,485 -2.4%
42.02
US$62,400 		1,485 -2.4% 42.02 US$62,400
2025-08-13 2025-08-13 PrS Proposed sale
Doyle James Edward

Director

Non-Executive Director
1,485
42.02
US$62,400 		1,485 42.02 US$62,400
2025-07-16 2025-07-16 PrS Proposed sale
2.9
Sebelius Kathleen

Former Director

Non-Executive Director
8,164
53.11
US$433,605 		8,164 53.11 US$433,605
2025-06-16 2025-06-13 PlS Planned sale
3.8
Zanotti Katherine S
Non-Executive Director
3,207 -4.2%
53.20
US$170,612 		3,207 -4.2% 53.20 US$170,612
2025-06-13 2025-06-13 PrS Proposed sale
3.8
Zanotti Katherine S

Director

Non-Executive Director
3,207
53.20
US$170,612 		3,207 53.20 US$170,612
2024-11-13 2024-11-13 B Purchase
1.8
Conroy Kevin T

President and CEO

Executive Director
19,500 +1.8%
51.35
US$1,001,325 		19,500 +1.8% 51.35 US$1,001,325
Explore more

More insider trading research around Exact Sciences Corp

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America